ACB:CA:TSX-Aurora Cannabis Inc (CAD)

COMMON STOCK | Drug Manufacturers—Specialty & Generic | TSX

Last Closing Price

CAD 21.20

Change

+0.15 (+0.71)%

Market Cap

CAD 2.43B

Volume

4.43M

Average Target Price

CAD 15.38 (-27.46%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topicals kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. As of September 11, 2019, the company had operations in 25 countries across five continents. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-05-28 )

Largest Industry Peers for Drug Manufacturers—Specialty & Generic

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WEED:CA Canopy Growth Corporation

+3.28 (+12.02%)

CAD10.68B N/A N/A
BHC:CA Bausch Health Companies Inc

+0.15 (+0.59%)

CAD9.12B N/A 23.92
CRON:CA Cronos Group Inc

+0.05 (+0.54%)

CAD3.25B 2.72 N/A
APHA:CA Aphria Inc

+0.23 (+4.03%)

CAD1.59B 45.75 12.49
GUD:CA Knight Therapeutics Inc

+0.02 (+0.27%)

CAD1.02B 75.60 23.34
CWEB:CA Charlotte's Web Holdings, Inc

-0.41 (-4.76%)

CAD0.89B 120.37 N/A
HLS:CA HLS Therapeutics Inc

-0.13 (-0.68%)

CAD0.61B N/A 29.62
OGI:CA OrganiGram Holdings Inc

+0.26 (+11.21%)

CAD0.45B 30.86 N/A
NEPT:CA Neptune Wellness Solutions Inc

-0.18 (-4.25%)

CAD0.39B 32.20 N/A
HEXO:CA HEXO Corp

-0.01 (-1.06%)

CAD0.38B N/A N/A

ETFs Containing ACB:CA

Symbol Name Weight Mer Price(Change) Market Cap
HMMJ-U:CA Horizons Marijuana Life S.. 9.76 % 0.86 %

+0.23 (+4.16%)

N/A
SEED:CA Evolve Marijuana Fund 8.62 % 0.75 %

N/A

CAD3.63M
HMMJ:CA Horizons Marijuana Life S.. 5.59 % 0.75 %

+0.16 (+1.97%)

CAD0.39B

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers—Specialty & Generic)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -36.68% 28% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.68% 28% F 14% F
Trailing 12 Months  
Capital Gain -83.88% 20% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -83.88% 20% F 1% F
Trailing 5 Years  
Capital Gain 460.85% 88% B+ 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 460.85% 88% B+ 98% A+
Average Annual (5 Year Horizon)  
Capital Gain 152.52% 100% A+ 99% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 152.52% 100% A+ 99% A+
Risk Return Profile  
Volatility (Standard Deviation) 172.06% 11% F 2% F
Risk Adjusted Return 88.65% 100% A+ 89% B+
Market Capitalization 2.43B 90% A- 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers—Specialty & Generic)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 1,171.00 6% F 0% N/A
Price/Book Ratio 0.59 90% A- 75% C
Price / Cash Flow Ratio N/A N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -34.62% 41% F 16% F
Return on Invested Capital -7.85% 62% D- 16% F
Return on Assets -3.97% 55% F 22% F
Debt to Equity Ratio 9.01% 57% F 84% B
Technical Ratios  
Short Ratio 2.08 69% D+ 39% F
Short Percent N/A N/A N/A N/A N/A
Beta 1.40 70% C- 28% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector